Seifeddine Ben Hammouda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Seifeddine Ben Hammouda has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
Manel Njima
Department of Pathology, Fattouma Bourguiba University Hospital, Monastir, 5000, Tunisia; Faculty of Medicine, University of Monastir, Monastir, 5000, Tunisia
5 shared publicationsNouha Ben Abdeljelil
Laboratoire d´Anatomie et Cytologie Pathologiques, Centre Hospitalier Universitaire Fattouma Bourguiba Monastir, Monastir, 5000, Tunisie
5 shared publicationsRim Hadhri
Department of Pathology, Fattouma Bourguiba University Hospital, Monastir, 5000, Tunisia; Faculty of Medicine, University of Monastir, Monastir, 5000, Tunisia
5 shared publicationsAbdelfatteh Zakhama
Department of Pathology, Fattouma Bourguiba University Hospital, Monastir 5000, Tunisia; Faculty of Medicine, University of Monastir, Monastir 5000, Tunisia
4 shared publicationsAhlem Bellalah
Department of Pathology, Fattouma Bourguiba University Hospital, Monastir 5000, Tunisia; Faculty of Medicine, University of Monastir, Monastir 5000, Tunisia
4 shared publicationsLeila Njim
Department of Pathology, Fattouma Bourguiba University Hospital, Monastir 5000, Tunisia; Faculty of Medicine, University of Monastir, Monastir 5000, Tunisia
3 shared publications
Latest Publications
- Open Access
- 29 April 2026
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 20 (1)
Intestinal T-cell lymphoma not otherwise specified presenting with Jejunal perforation: a case report and review of the literature
Primary gastrointestinal lymphomas are rare, with the small intestine being the second most frequently involved site after the stomach. Intestinal perforat
- 29 April 2026
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 20 (1)
Open AccessIntestinal T-cell lymphoma not otherwise specified presenting with Jejunal perforation: a case report and review of the literature
Primary gastrointestinal lymphomas are rare, with the small intestine being the second most frequently involved site after the stomach. Intestinal perforat
- 22 July 2023
- Published by Elsevier in Legal Medicine
- Vol. 64, 102299
A case of suspected primary mediastinal large B-cell lymphoma: An uncommon cause of sudden death
- 22 July 2023
- Published by Elsevier in Legal Medicine
- Vol. 64, 102299
A case of suspected primary mediastinal large B-cell lymphoma: An uncommon cause of sudden death
- 18 April 2023
- Published by Elsevier in Journal of Forensic and Legal Medicine
- Vol. 96, 102527
Sudden death due to Takayasu arteritis complication associated with situs inversus totalis: A case discovered at autopsy
- 18 April 2023
- Published by Elsevier in Journal of Forensic and Legal Medicine
- Vol. 96, 102527
Sudden death due to Takayasu arteritis complication associated with situs inversus totalis: A case discovered at autopsy
- Open Access
- 5 November 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 84, 104818
Primary retroperitoneal mucinous cystadenoma: A case report with review of literature
Primary Retroperitoneal mucinous cystadenoma (PRMC) is an extremely rare benign tumor, predominantly occurring in women, with unclear pathogenesis. A 31-year-old woman, with no medical or surgical history, presented with left flank pain. An abdominal computed tomography (CT) scan revealed an 11cm retroperitoneal cyst. Due to its large size, percutaneous CT-guided drainage followed by a laparotomy surgical resection, were performed. Post-operative course was uneventful. Histological and immunohistochemical findings were consistent with PRMC. The patient was disease-free after a 6-month follow-up. Mucinous cystadenoma is a very odd finding in the retroperitoneum. Multiple differential diagnoses are to be considered beforehand, as most of cystic lesions in this anatomical region are malignant and require a different surgical approach. Radical resection, by laparotomy or laparoscopy, is the treatment of choice.
- 5 November 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 84, 104818
Open AccessPrimary retroperitoneal mucinous cystadenoma: A case report with review of literature
Primary Retroperitoneal mucinous cystadenoma (PRMC) is an extremely rare benign tumor, predominantly occurring in women, with unclear pathogenesis. A 31-year-old woman, with no medical or surgical history, presented with left flank pain. An abdominal computed tomography (CT) scan revealed an 11cm retroperitoneal cyst. Due to its large size, percutaneous CT-guided drainage followed by a laparotomy surgical resection, were performed. Post-operative course was uneventful. Histological and immunohistochemical findings were consistent with PRMC. The patient was disease-free after a 6-month follow-up. Mucinous cystadenoma is a very odd finding in the retroperitoneum. Multiple differential diagnoses are to be considered beforehand, as most of cystic lesions in this anatomical region are malignant and require a different surgical approach. Radical resection, by laparotomy or laparoscopy, is the treatment of choice.
- Open Access
- 16 May 2022
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 95 (C) , 107201
Large splenic epithelial cyst
Introduction and importance: Splenic cysts are infrequent and most of them are related to parasitic diseases. Splenic epithelial cyst (SEC) is the most common type of primary non-parasitic splenic cysts. Its pathogenesis is not yet clear. Splenic cysts are usually asymptomatic and are detected incidentally during imaging exams or an exploratory laparotomy. Case presentation: Our case is about a primary SEC discovered incidentally. An 18-year-old male patient without any personal and family medical history, presented with symptoms of upper urinary tract infection. Renal ultrasound was performed and found incidentally a solitary cystic lesion in the spleen. A laparoscopic partial splenectomy was made then. The specimen was sent for pathological examination and a diagnosis of primary (epidermoid) epithelial splenic cyst was given. Clinical discussion: SEC is a rare pathology that could mimic other splenic cysts like hydatid cyst. The preoperative diagnosis of SEC can be suspected by ultrasonography, computed tomography or magnetic resonance imaging. However, histopathological examination is mandatory to confirm the diagnosis. A wide range of differential diagnoses is considered when we suspect clinically SEC because of its lower incidence. Conclusion: Actually, spleen-preserving surgery with minimally invasive methods such as laparoscopy is the gold standard for the treatment of SEC despite the risk of recurrence encountered with these techniques. However, different surgical modalities are discussed depending on the size and the location of the cyst and the patient's age. Highlights:
- 16 May 2022
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 95 (C) , 107201
Open AccessLarge splenic epithelial cyst
Introduction and importance: Splenic cysts are infrequent and most of them are related to parasitic diseases. Splenic epithelial cyst (SEC) is the most common type of primary non-parasitic splenic cysts. Its pathogenesis is not yet clear. Splenic cysts are usually asymptomatic and are detected incidentally during imaging exams or an exploratory laparotomy. Case presentation: Our case is about a primary SEC discovered incidentally. An 18-year-old male patient without any personal and family medical history, presented with symptoms of upper urinary tract infection. Renal ultrasound was performed and found incidentally a solitary cystic lesion in the spleen. A laparoscopic partial splenectomy was made then. The specimen was sent for pathological examination and a diagnosis of primary (epidermoid) epithelial splenic cyst was given. Clinical discussion: SEC is a rare pathology that could mimic other splenic cysts like hydatid cyst. The preoperative diagnosis of SEC can be suspected by ultrasonography, computed tomography or magnetic resonance imaging. However, histopathological examination is mandatory to confirm the diagnosis. A wide range of differential diagnoses is considered when we suspect clinically SEC because of its lower incidence. Conclusion: Actually, spleen-preserving surgery with minimally invasive methods such as laparoscopy is the gold standard for the treatment of SEC despite the risk of recurrence encountered with these techniques. However, different surgical modalities are discussed depending on the size and the location of the cyst and the patient's age. Highlights:
- Open Access
- 12 May 2022
- Vol. 42, 30
[Triple negative breast cancer: clinical, pathological and molecular characteristics].
Triple-negative breast cancer (TNBC) is a very heterogeneous disease and refers to a subgroup of breast cancer. The purpose of this study was to describe the clinical, pathological and molecular features of TNBC. We conducted a retrospective analysis of 56 cases of TNBC diagnosed in the Department of Pathology at the Farhat Hached University Hospital over a period of three years (2018-2020). The incidence of TNBC was 5.62% and the mean age of the patients was 50.36 years. The most frequent reason for consultation was the discovery of breast nodules (98.21%). The diagnosis of TNBC was confirmed in 24 cases (42.86%) based on the analysis of mastectomy specimens. Invasive carcinoma of no special type (NST) was the most common histological type (47 cases; 82.5%). Mean tumor size was 35.5 mm. SBR grading was only specified in 42 cases (73.68%). Grade III was the most predominant type (78.6%, n = 33). The notion of lymph node metastasis was found in 44 reports and lymph node invasion was reported in 19 patients (43.2%). Immunohistochemical study showed that all patients were hormone receptor-negative (RO and RP) with no Her2 overexpression (n = 56; 100). This study results are generally in agreement with literature data. Despite recent molecular classifications, there is no clinically verified diagnostic test allowing for clear therapeutic standardization.
- 12 May 2022
- Vol. 42, 30
Open Access[Triple negative breast cancer: clinical, pathological and molecular characteristics].
Triple-negative breast cancer (TNBC) is a very heterogeneous disease and refers to a subgroup of breast cancer. The purpose of this study was to describe the clinical, pathological and molecular features of TNBC. We conducted a retrospective analysis of 56 cases of TNBC diagnosed in the Department of Pathology at the Farhat Hached University Hospital over a period of three years (2018-2020). The incidence of TNBC was 5.62% and the mean age of the patients was 50.36 years. The most frequent reason for consultation was the discovery of breast nodules (98.21%). The diagnosis of TNBC was confirmed in 24 cases (42.86%) based on the analysis of mastectomy specimens. Invasive carcinoma of no special type (NST) was the most common histological type (47 cases; 82.5%). Mean tumor size was 35.5 mm. SBR grading was only specified in 42 cases (73.68%). Grade III was the most predominant type (78.6%, n = 33). The notion of lymph node metastasis was found in 44 reports and lymph node invasion was reported in 19 patients (43.2%). Immunohistochemical study showed that all patients were hormone receptor-negative (RO and RP) with no Her2 overexpression (n = 56; 100). This study results are generally in agreement with literature data. Despite recent molecular classifications, there is no clinically verified diagnostic test allowing for clear therapeutic standardization.
- 11 May 2022
- Published by Elsevier in Journal of Forensic and Legal Medicine
- Vol. 89, 102369
Sudden death due to cirrhotic cardiomyopathy: An autopsy case report
- 11 May 2022
- Published by Elsevier in Journal of Forensic and Legal Medicine
- Vol. 89, 102369
Sudden death due to cirrhotic cardiomyopathy: An autopsy case report
- 27 April 2022
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 89 (2) , 536-540
Erythema nodosum induced by Covid‐19 Pfizer‐BioNTech mRNA vaccine: A case report and brief literature review
Erythema nodosum (EN), the most common form of panniculitis, is a reactive inflammation of the subcutaneous fat clinically presented with a sudden onset of painful, erythematous, nodular, subcutaneous lesions, typically localized to the pretibial area. EN is commonly caused by numerous infections (especially beta‐haemolytic streptococcal infections), autoimmune diseases (sarcoidosis), inflammatory bowel conditions and drugs. EN induced by Covid‐19 vaccines is rarely reported. We describe an original clinical observation of a 75‐year‐old woman who presented with EN after receiving the second dose of BNT162b2, an mRNA vaccine.
- 27 April 2022
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 89 (2) , 536-540
Erythema nodosum induced by Covid‐19 Pfizer‐BioNTech mRNA vaccine: A case report and brief literature review
Erythema nodosum (EN), the most common form of panniculitis, is a reactive inflammation of the subcutaneous fat clinically presented with a sudden onset of painful, erythematous, nodular, subcutaneous lesions, typically localized to the pretibial area. EN is commonly caused by numerous infections (especially beta‐haemolytic streptococcal infections), autoimmune diseases (sarcoidosis), inflammatory bowel conditions and drugs. EN induced by Covid‐19 vaccines is rarely reported. We describe an original clinical observation of a 75‐year‐old woman who presented with EN after receiving the second dose of BNT162b2, an mRNA vaccine.
- Open Access
- 1 January 2022
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 41 (184) , 184
Fibromatose desmoïde mammaire: à propos de deux cas et revue de la littérature
La fibromatose mammaire est une tumeur mammaire bénigne d´origine mésenchymateuse, elle représente 0.2% des tumeurs du sein. Cet article relate deux observations de fibromatose mammaire étayant ses particularités diagnostiques, morphologiques, thérapeutiques et évolutives. Dans les deux cas, la tumeur mime sur le plan clinique et radiologique un cancer. La confirmation diagnostique est obtenue par une preuve histologique. La fibromatose mammaire se caractérise par une évolution locale et une tendance à la récidive, d´où l´intérêt de l´exérèse chirurgicale avec marges saines obtenues chez nos patientes. La place des traitements locorégionaux (la radiothérapie et la cryothérapie) et des traitements médicaux, en particulier les anti-estrogènes n´est pas clairement définie. En conclusion, la fibromatose mammaire doit être connue puisqu´elle mime en tout point un cancer de sein et se caractérise par un taux de récidive très important sans jamais donner de métastases.
- 1 January 2022
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 41 (184) , 184
Open AccessFibromatose desmoïde mammaire: à propos de deux cas et revue de la littérature
La fibromatose mammaire est une tumeur mammaire bénigne d´origine mésenchymateuse, elle représente 0.2% des tumeurs du sein. Cet article relate deux observations de fibromatose mammaire étayant ses particularités diagnostiques, morphologiques, thérapeutiques et évolutives. Dans les deux cas, la tumeur mime sur le plan clinique et radiologique un cancer. La confirmation diagnostique est obtenue par une preuve histologique. La fibromatose mammaire se caractérise par une évolution locale et une tendance à la récidive, d´où l´intérêt de l´exérèse chirurgicale avec marges saines obtenues chez nos patientes. La place des traitements locorégionaux (la radiothérapie et la cryothérapie) et des traitements médicaux, en particulier les anti-estrogènes n´est pas clairement définie. En conclusion, la fibromatose mammaire doit être connue puisqu´elle mime en tout point un cancer de sein et se caractérise par un taux de récidive très important sans jamais donner de métastases.
- Open Access
- 1 January 2022
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 41 (73) , 73
A rare mixed ovarian tumor associating borderline endometrioid component and borderline serous component
A 37-year-old woman was admitted to the department of Gynecology and Obstetrics for management of ovarian cyst, for which a left oophorectomy was performed. The specimen was evaluated then in the department of pathology. On gross examination, the ovarian cyst had a smooth surface and measured 5.5x4.5x 2.5cm. Cut section revealed that the cyst was multilocular, filled with clear fluid and containing several buds. Microscopically, the cyst consisted in a biphasic tumor associating borderline endometrioid component, composed of confluent glands of endometrioid-type epithelium with mild atypical nuclei and borderline serous component. This serous component was made by numerous bulbous, irregularly contoured papillae with fibrous cores and lined by pseudostratified columnar cells with moderate atypia. Immunohistochemical study using WT1 showed positive labeling in the borderline serous component (blue asterisk) and absence of labeling in the borderline endometrioid component (red asterisk). The diagnosis of a mixed ovarian tumor associating a borderline endometrioid component and a borderline serous component was given. A mixed tumor associating two types of ovarian borderline tumors is exceptionally described in the literature. In our case, the presence of a borderline endometrioid component associated with a borderline serous component raises the role of endometriosis in the genesis of ovarian tumors. The pathogenetic transformation from endometriosis to ovarian tumors is not fully understood, but it seems mainly related to many factors: inflammation, oxidative stress, hyperestrogenism, and specific genomic alterations.
- 1 January 2022
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 41 (73) , 73
Open AccessA rare mixed ovarian tumor associating borderline endometrioid component and borderline serous component
A 37-year-old woman was admitted to the department of Gynecology and Obstetrics for management of ovarian cyst, for which a left oophorectomy was performed. The specimen was evaluated then in the department of pathology. On gross examination, the ovarian cyst had a smooth surface and measured 5.5x4.5x 2.5cm. Cut section revealed that the cyst was multilocular, filled with clear fluid and containing several buds. Microscopically, the cyst consisted in a biphasic tumor associating borderline endometrioid component, composed of confluent glands of endometrioid-type epithelium with mild atypical nuclei and borderline serous component. This serous component was made by numerous bulbous, irregularly contoured papillae with fibrous cores and lined by pseudostratified columnar cells with moderate atypia. Immunohistochemical study using WT1 showed positive labeling in the borderline serous component (blue asterisk) and absence of labeling in the borderline endometrioid component (red asterisk). The diagnosis of a mixed ovarian tumor associating a borderline endometrioid component and a borderline serous component was given. A mixed tumor associating two types of ovarian borderline tumors is exceptionally described in the literature. In our case, the presence of a borderline endometrioid component associated with a borderline serous component raises the role of endometriosis in the genesis of ovarian tumors. The pathogenetic transformation from endometriosis to ovarian tumors is not fully understood, but it seems mainly related to many factors: inflammation, oxidative stress, hyperestrogenism, and specific genomic alterations.